Edward Mascioli, M.D.CEO, Karos Pharmaceuticals

    CEO, Karos Pharmaceuticals; previously, Venture Partner, SV Life Sciences, Board Director, NKT Therapeutics; CEO, Affinium Pharmaceuticals. Prior to Affinium, established and led the Rare Disease Unit at Pfizer.